Panacea Biotec is engaged in research, manufacturing and marketing of pharmaceuticals, biopharmaceuticals, new chemical entities, natural products and vaccines.
The product portfolio includes therapeutic areas like pain management, diabetes & cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal care products and vaccines.
In the field of vaccines, Panacea Biotec has to its credit development of monovalent type 1 oral polio vaccine (mOPV1), in addition to the conventional trivalent oral polio. Panacea Biotec vaccine formulation plant, New Delhi, has been commissioned with an installed capacity of 3.25 million vials per annum.
The company has a New Drug Discovery Research Centre in Punjab to develop new chemical entities, Biopharmaceutical Research Centre in New Delhi focusing on novel vaccines, peptides and monoclonal antibodies and Global Research & Development Centre, Navi Mumbai to develop advanced drug delivery research based products. Panacea Biotec also has a formulation plant in Baddi, Himachal Pradesh.